Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMyriad Genetics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.11 | -$0.10 | -$0.10 |
| Q2 2024 | 6 | -$0.01 | -$0.01 | -$0.01 |
| Q3 2024 | 4 | $0.02 | $0.02 | $0.02 |
| Q4 2024 | 11 | $0.02 | $0.03 | $0.03 |
| Q1 2025 | 9 | -$0.02 | $0.01 | -$0.00 |
| Q2 2025 | 8 | $0.02 | $0.02 | $0.02 |
| Q3 2025 | 4 | $0.03 | $0.03 | $0.03 |
| Q4 2025 | 5 | $0.05 | $0.06 | $0.05 |
| Q1 2026 | 5 | $0.06 | $0.06 | $0.06 |
| Q2 2026 | 3 | $0.08 | $0.09 | $0.08 |
| Q3 2026 | 3 | $0.07 | $0.08 | $0.08 |
| Q4 2026 | 5 | $0.10 | $0.10 | $0.10 |
Myriad Genetics, Inc. Earnings Date And Information
Myriad Genetics, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $0.06 earnings per share for the quarter, topping analysts' consensus estimates of $0.019 by $0.041. The company had revenue of 213.30 M for the quarter and had revenue of 753.20 M for the year. Myriad Genetics, Inc. has generated $-3 earnings per share over the last year ($-3.18 diluted earnings per share) and currently has a price-to-earnings ratio of -10.52. Myriad Genetics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based on prior year's report dates.
Myriad Genetics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/08/2024 | Q3 2024 | -$0.24 | $210.76 M | $213.30 M | ||
| 08/07/2024 | Q2 2024 | -$0.41 | $206.44 M | $211.50 M | ||
| 05/08/2024 | Q1 2024 | -$0.29 | $202.20 M | |||
| 02/28/2024 | Q4 2023 | -$0.36 | $196.60 M | |||
| 11/07/2023 | Q3 2023 | -$0.75 | $182.32 M | $191.90 M | ||
| 08/04/2023 | Q2 2023 | -$1.42 | $187.16 M | $183.50 M | ||
| 05/04/2023 | Q1 2023 | -$0.67 | $181.20 M | |||
| 03/01/2023 | Q4 2022 | -$0.52 | $177.80 M | |||
| 11/02/2022 | Q3 2022 | -$0.43 | $170.07 M | $156.40 M | ||
| 08/05/2022 | Q2 2022 | -$0.18 | $170.96 M | $179.30 M | ||
| 05/06/2022 | Q1 2022 | -$0.26 | $164.90 M | |||
| 02/25/2022 | Q4 2021 | -$0.10 | $160.80 M | |||
| 11/04/2021 | Q3 2021 | $0.31 | $165.04 M | $167.30 M | ||
| 08/04/2021 | Q2 2021 | -$0.06 | $162.54 M | $189.40 M | ||
| 05/05/2021 | Q1 2021 | -$0.52 | $173.10 M | |||
| 12/31/2020 | Q4 2020 | -$0.59 | $154.60 M | |||
| 11/09/2020 | Q3 2020 | -$0.33 | -$0.20 | 0.13 | $167.38 M | $145.20 M |
| 08/13/2020 | Q2 2020 | -$0.36 | -$0.74 | -0.38 | $209.66 M | $93.20 M |
| 05/05/2020 | Q1 2020 | -$1.55 | $164.00 M | |||
| 02/06/2020 | Q4 2019 | -$0.11 | $195.10 M |
Myriad Genetics, Inc. Earnings: FAQ's
When is Myriad Genetics, Inc.'s earnings date?
Myriad Genetics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates.
Did Myriad Genetics, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Myriad Genetics, Inc. (:MYGN) reported $0.06 earnings per share (EPS) to beat the analysts' consensus estimate of $0.019 by $0.041.
How can I listen to Myriad Genetics, Inc.'s earnings conference
call?
The conference call for Myriad Genetics, Inc.'s latest earnings report can be listened to online.
How can I read Myriad Genetics, Inc.'s conference call transcript?
The conference call transcript for Myriad Genetics, Inc.'s latest earnings report can be read online.
How much revenue does Myriad Genetics, Inc. generate each year?
Myriad Genetics, Inc. (:MYGN) has a recorded annual revenue of $753.20 M.
How much profit does Myriad Genetics, Inc. generate each year?
Myriad Genetics, Inc. (:MYGN) has a recorded net income of $753.20 M. Myriad Genetics, Inc. has generated $-3.18 earnings per share over the last four quarters.
What is Myriad Genetics, Inc.'s price-to-earnings ratio?
Myriad Genetics, Inc. (:MYGN) has a price-to-earnings ratio of -10.52 and price/earnings-to-growth ratio is -0.37.